INTERVENTIONAL CARDIOLOGY DEVICES MARKET ANALYSIS

Interventional Cardiology Devices Market, By Device (Angiography Catheters, IVUS, PTCA Guidewires, Guiding Catheters, Balloon Inflation Devices, Stents), By End User (Hospitals, Clinics, Ambulatory Surgical Centers), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Published In : Sep 2020
Code : CMI691
Pages :173
Formats :
Excel and PDF
Industry : Medical Devices

Leading Companies

Global Interventional Cardiology Devices Market: Competitive Landscape

Major players operating in the global interventional cardiology devices market include, Abbott Laboratories, Terumo Medical Corporation, Boston Scientific Corporation, Cardinal Health, Medtronic, Cook Medical, SINOMED, Biotronik SE & Co. KG, and B. Braun Melsungen AG.

Global Interventional Cardiology Devices Market: Key Developments

Major players in the global interventional cardiology devices market are focused on R&D to expand their product portfolio. For instance, in July 2019, SINOMED completed enrollment in the PIONEER III randomized, controlled clinical trial to assess the safety and effectiveness of the BuMA Supreme DES in order to obtain key regulatory approvals for the BuMA Supreme Drug-Eluting Stent (DES) System.

Companies covered:

Abbott Laboratories, Terumo Medical Corporation, Boston Scientific Corporation, Cardinal Health, Medtronic, Cook Medical, SINOMED, Biotronik SE & Co. KG, and B. Braun Melsungen AG.